Waldenström's Macroglobulinemia

What is Waldenström's macroglobulinemia?

Waldenström's macroglobulinemia is a rare type of blood cancer that starts in white blood cells called B lymphocytes. These cells normally help your immune system fight infections by producing antibodies. In this condition, cancer cells grow in your bone marrow and produce too much of one specific antibody called immunoglobulin M, or IgM.

When IgM levels get too high, your blood becomes thicker than normal. Doctors call this hyperviscosity. Think of it like motor oil that has gotten too thick to flow properly. This thick blood can make it harder for oxygen and nutrients to reach your tissues. The condition grows slowly and is classified as a type of non-Hodgkin lymphoma.

About 1,500 people are diagnosed with Waldenström's macroglobulinemia in the United States each year. It usually affects people over age 60. Men develop it slightly more often than women. While there is no cure, many people live for years with proper treatment and monitoring.

IgM

Pinpoint the cause of recurring infections
Reveal hidden immune system issues
Clarify unexplained symptoms quickly

^$105

Symptoms

Fatigue and weakness that does not improve with rest
Easy bruising or bleeding, including nosebleeds and bleeding gums
Unexplained weight loss over several months
Swollen lymph nodes in your neck, armpits, or groin
Enlarged spleen or liver that may cause abdominal discomfort
Numbness or tingling in your hands and feet
Vision problems or blurred vision
Headaches or dizziness
Shortness of breath during normal activities
Frequent infections

Many people have no symptoms in the early stages. The condition is sometimes found during routine blood work done for another reason. Symptoms typically develop slowly over months or years as IgM levels rise.

Causes and risk factors

The exact cause of Waldenström's macroglobulinemia is not fully understood. It happens when DNA changes occur in B lymphocytes, causing them to grow out of control and produce excessive IgM. These changes are not inherited in most cases. Researchers have found that more than 90% of people with this condition have a specific gene mutation called MYD88 L265P.

Risk factors include being over age 60, being male, being white, and having a family history of this condition or related blood disorders. People with hepatitis C infection may have a slightly higher risk. Having an IgM antibody disorder called IgM monoclonal gammopathy of undetermined significance increases your risk. However, most people with these risk factors never develop the condition.

How it's diagnosed

Diagnosis starts with blood tests that measure different types of proteins and antibodies in your blood. An immunoglobulin M test can detect high levels of IgM antibodies. Your doctor will also order a complete blood count to check for anemia and low platelet counts. A serum protein electrophoresis test can identify abnormal proteins.

If blood tests suggest Waldenström's macroglobulinemia, your doctor will perform a bone marrow biopsy. This involves taking a small sample of bone marrow, usually from your hip bone, to look for cancer cells under a microscope. Genetic testing on the bone marrow can identify specific mutations. Talk to a doctor about specialized testing if you have symptoms or abnormal blood work.

Treatment options

Active monitoring without immediate treatment if you have no symptoms
Chemotherapy medications to slow cancer cell growth
Targeted therapy drugs that attack specific proteins in cancer cells
Immunotherapy to help your immune system fight cancer cells
Plasmapheresis to remove excess IgM from your blood quickly
Stem cell transplant in some cases for younger, healthier patients
Regular blood tests to monitor IgM levels and blood counts
Treatment for anemia with medications or blood transfusions
Preventing infections with vaccinations and sometimes antibiotics
Working with a blood cancer specialist called a hematologist-oncologist

Frequently asked questions

Both are blood cancers that affect antibody-producing cells, but they involve different cell types and antibodies. Waldenström's macroglobulinemia produces too much IgM antibody and grows in bone marrow and lymph nodes. Multiple myeloma usually produces IgG or IgA antibodies and causes bone damage. Treatment approaches differ between these two conditions.

Currently there is no cure for Waldenström's macroglobulinemia. However, many people live for 10 to 20 years or longer with treatment. The condition grows slowly in most cases. Treatment can control symptoms, reduce IgM levels, and help you maintain a good quality of life for many years.

High IgM levels without symptoms may indicate early-stage disease or a related condition called IgM monoclonal gammopathy. Your doctor will likely recommend regular monitoring with blood tests every few months. Many people go years without needing treatment. Treatment typically starts only when symptoms develop or IgM levels become very high.

Testing frequency depends on your disease stage and whether you are receiving treatment. People on active monitoring without treatment typically get blood work every 3 to 6 months. During treatment, you may need monthly blood tests to check how well therapy is working and monitor for side effects. Your care team will create a testing schedule based on your individual needs.

Hyperviscosity syndrome happens when blood becomes too thick from excess IgM protein. Symptoms include headaches, vision changes, bleeding, and confusion. This is a medical emergency that requires immediate treatment called plasmapheresis. This procedure filters your blood to remove excess IgM protein quickly, usually providing relief within hours.

Eating a balanced diet rich in fruits, vegetables, and lean protein supports overall health during treatment. Staying physically active as your energy allows can reduce fatigue. Avoiding sick people and practicing good hand hygiene helps prevent infections. Getting adequate sleep and managing stress are also important for supporting your immune system.

Many people do not need immediate treatment after diagnosis. If your IgM levels are only slightly elevated and you have no symptoms, your doctor may recommend a watch-and-wait approach. Treatment typically starts when you develop symptoms, IgM levels rise significantly, or blood counts become too low. This approach is called active monitoring or watchful waiting.

Family history does increase risk slightly. About 20% of people with this condition have a relative with Waldenström's macroglobulinemia or a related blood disorder. However, most cases occur in people with no family history. Genetic counseling may be helpful if multiple family members are affected.

Side effects vary depending on which treatment you receive. Chemotherapy can cause fatigue, nausea, hair loss, and increased infection risk. Targeted therapies may cause diarrhea, rash, or muscle pain. Most side effects are manageable with medications or dose adjustments. Your care team will monitor you closely and help manage any side effects that occur.

Your doctor will track your IgM levels with regular blood tests. Successful treatment typically reduces IgM levels by at least 50%. Your symptoms should improve and your blood counts should return toward normal. Imaging tests may be used to check if enlarged lymph nodes or organs have decreased in size.